With the annual ADA Scientific sessions this past week, there were many announcements and press releases from companies. I’ll be sharing a few that stood out to me…
DexCom’s Forthcoming Mobile App Platform to Integrate Data from Insulet’s OmniPod System
“Insulet Corporation (PODD) and DexCom, Inc. (DXCM) announced today their intention to enable DexCom’s mobile App platform, which is currently under development, to integrate data from Insulet’s OmniPod System. This will be the first version of a mobile App that is capable of incorporating glucose and other diabetes-related data from patients’ devices and displaying the integrated data via a smartphone App. This event also marks the start of DexCom’s open architecture approach to diabetes-related data which will include an “approved by DexCom” indication to validate the authenticity of devices and Apps integrating DexCom CGM data.” (Read the entire press release.)
My take: I find it interesting that DexCom and Insulet are partnering given that DexCom and Insulet ended their partnership to develop an integrated insulin pump and continuous glucose monitor. Insult is now partnered with an unnamed company working on CGM integration.
I would really like to just plug our DexCom or OmniPod into my Mac to download the data in a meaningful way. You would think that would be relatively simple. Some parents are excited about DexCom Share which is in the FDA approval process right now. I’m not sure if Share will be right for our family, but I am looking to the next step (which may include this app) where the Dex can transmit straight to a phone.
Read “I’m a Mac, Diabetes is a PC” blog posts.
(Disclosure: I write for Insulet’s Suite D blog, but they did not ask me to write about this press release.)